Items Tagged ‘rising psa’

February 19, 2018

Erleada is The First Treatment for Non-metastatic Castration-resistant Prostate Cancer

By

CancerConnect News:  Men who are being treated with androgen deprivation therapy (ADT) and see their prostate specific antigen (PSA) levels begin to increase have a new treatment option. The U.S. Food and Drug Administration (FDA) has approved Erleada (Apalutamide) for the treatment of non-metastatic castration-resistant prostate cancer (CRPC).1  There were previously no FDA-approved treatments for […]

View full entry

Tags: Apalutamide, Erleada, News, non-metastatic castration-resistant prostate cancer, Prostate Cancer, rising psa, treatment